Overview

Insomnia and Daytime Function in Osteoarthritis

Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of zolpidem at doses up to 10 mg compared to placebo in patients with insomnia associated with osteoarthritis
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Zolpidem